Two new studies have revealed that the proportion of adolescents living with overweight or obesity in England has increased by 50 % from 2008-2010 (22%) to 2021-2023 (33%).
Three-year rolling prevalences for overweight and obesity were calculated, since these provide more stable estimates, and a clearer picture of the longer-term trends rather than focusing on small year-to-year changes.
(Source: Pixabay)
Bristol/UK – Previous research has shown overweight and obesity during adolescence are associated with increased morbidity. In the first study, the authors aimed to estimate the prevalence of overweight and obesity among adolescents in England using routinely collected healthcare data. In the second study, the authors also investigated the association between adolescent body mass index (BMI) and the onset of co-morbid conditions during adolescence.
The studies were led by Dr Dinesh Giri, Honorary Senior Lecturer at Bristol Medical School at the University of Bristol and Consultant Paediatric Endocrinologist from Bristol Royal Hospital for Children, and Dr Senthil Senniappan, Consultant Paediatric Endocrinologist at Alder Hey Children’s Hospital.
The researchers used linked primary (Clinical Practice Research Datalink [CPRD]) and secondary (Hospital Episode Statistics) care data for
their analysis.
Among adolescents aged 12-17 years registered at a CPRD contributing practice (around 20 % of practices nationwide contribute) from 2008-2023 with BMI readings and using the UK 1990 growth reference centiles (a widely-used reference for studies of this type). Overweight was defined as at or above the 91st centile and obesity as at or above the 98th centile.
Three-year rolling prevalences for overweight and obesity were calculated, since these provide more stable estimates, and a clearer picture of the longer-term trends rather than focusing on small year-to-year changes. The authors explain this helps to smooth out any random ups and downs that might happen in a single year.
Adolescents with a healthy weight BMI, at or above the 2nd and below the 91st centile, were included as a comparator. The sociodemographic
and clinical characteristics for adolescents were described at the first BMI recording. The incidence of new comorbidities during adolescence was compared between adolescents living with overweight or obesity and those with healthy weight using statistical modelling.
The period prevalence of overweight and obesity increased from 22 % in 2008-2010 to 33 % in 2021-2023. There was evidence of a steeper increase during / following the Covid-19 pandemic.
Of the 139,258 adolescents living as overweight, 140,990 adolescents with obesity and 560,789 adolescents with healthy weight, higher proportions with overweight (26 %) or obesity (31 %) than healthy weight (22 %) resided in the most deprived geographies (calculated by decile, or groups of 10 %).
Higher proportions of those living with overweight (8 %) and obesity (27 %) had lived with obesity during childhood than those with healthy weight (1 %). New onset of mental health (obesity: 8.6 % vs overweight: 7.8 % vs healthy weight: 7.1 %), physical (11.6 % vs 10.7 % vs 9.3 %) and cardiometabolic (3.1 % vs 1.2 % vs 0.5 %) comorbidities during adolescence was higher in adolescents living with obesity than overweight and lowest in those with healthy weight.
The second study investigated other comorbidities in more detail. Out of the 15 comorbidities investigated, the risks of 14 were significantly higher in adolescents living with overweight or obesity compared to those with healthy weight.
Over a mean follow-up of six years, the risk (Figure 1 of second abstract) of many comorbidities was higher in adolescents living with overweight (n=139,258) or obesity (n=140,990) than those with healthy weight (n=560,789), specifically; obstructive sleep apnoea (3 times higher [overweight] and 8 times higher [obesity]), type 2 diabetes (3 and 11 times higher) and metabolic dysfunction-associated steatotic liver disease (3 and 12 times higher), prediabetes (2 and 4 times higher) and polycystic ovary syndrome (PCOS) (2 and 4 times higher).
The authors conclude: “The burden of overweight and obesity among adolescents in England is substantial and increased between 2008-2023. There is a significantly higher risk of early onset of many, particularly cardiometabolic, comorbidities among adolescents living with overweight or obesity, with risk increasing as BMI increases.”
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
They add: “Over the past 15 years, obesity in adolescents has risen significantly due to a combination of increased consumption of ultra-processed foods, sedentary lifestyles driven by excessive screen time, inadequate sleep, and rising mental health challenges. Additionally, reduced opportunities for physical activity and socioeconomic disparities have further contributed to an environment that promotes unhealthy lifestyles.”
On comorbidities, they say: “For many weight-related comorbidities, overweight and obesity in adolescence are associated with a higher risk during both adolescence and adulthood. Change of BMI in adolescence may have long-term impact on the risk of developing comorbidities. Increased focus on weight-management in adolescence could lead to long-term improvement in overall health.”
The study was funded by Novo Nordisk.
Papers: 'Estimating the prevalence of overweight and obesity and the incidence of comorbidities in adolescents living with overweight and obesity: a cohort study using routinely collected healthcare data in England between 2008 and 2023' by D Giri et al.
'Estimating the effect of overweight and obesity during adolescence on the risk of long-term comorbidities: a population-based retrospective analysis in England between 2008 and 2023; by S Senniappan et al.